Researchers performed a secondary analysis of a phase 3 trial involving 785 patients with advanced gastric or gastroesophageal junction cancer. The study looked at coronary artery calcification (CAC) scores, which are measured using CT scans to look at the heart's arteries. The goal was to see if these scores could help predict how long patients would live while undergoing first-line chemotherapy.
The results showed that while male patients had significantly higher CAC scores than female patients, the actual score did not correlate with survival. Whether the calcification was measured as a continuous number or simply as being present or absent, there was no significant link to the length of time patients lived.
Because this was a secondary analysis of baseline images, the findings are specific to this study group. For patients with advanced gastric or esophageal junction cancer, these heart scores do not currently provide useful information for predicting outcomes. Patients should continue to discuss their specific treatment plans and prognosis with their oncology team.
Common questions
What is coronary artery calcification (CAC)?
Coronary artery calcification refers to the buildup of calcium in the heart's arteries. In this study, researchers used CT scans to calculate a CAC score. While the study found that men had significantly higher scores than women (median 1 vs 0), these scores did not change the predicted survival for patients with gastric or esophageal junction cancer.
Does a high heart calcium score affect cancer treatment?
In this specific study of 785 patients, the heart's calcium score did not have a significant association with survival. Whether the score was measured as a continuous value or just as the presence of calcium, it did not impact the outcome for patients undergoing first-line chemotherapy. You should talk to your doctor about your specific treatment.
Who was included in this study?
The study included 785 patients who had unresectable locally advanced or metastatic gastric or gastroesophageal junction cancer. The researchers looked at these patients' baseline CT images to see if heart health markers could help predict their survival during chemotherapy.
